4893 items matching your search terms.

Impact of KRAS and BRAF gene mutation status on outcomes from the phase III AGITG MAX trial of capecitabine alone or in combination with bevacizumab and mitomycin in advanced colorectal cancer

Price, TJ Hardingham, JE Lee, CK Weickhardt, A Townsend, AR Wrin, JW Chua, A Shivasami, A Cummins, MM Murone, C Tebbutt, NC
JOURNAL OF CLINICAL ONCOLOGY, 2011     DOI:10.1200/JCO.2010.34.5520

Geriatric subgroup of AGITG MAX trial: International randomized phase III trial of capecitabine, bevacizumab, and mitomycin C; first-line metastatic colorectal cancer

Price, T Zannino, D Wilson, K van Hazel, G Robinson, B Broad, A Ganju, V Ackland, S Simes, J Tebbutt, N

Outcome and dose intensity in the elderly subgroup of the AGITG MAX phase III trial of capecitabine, bevacizumab, and mitomycin C in first-line metastatic colorectal cancer

Price, TJ; Zannino, D; Wilson, K; Simes, J; Van Hazel, GA; Robinson, BA; Broad, A; Ganju, V; Ackland, SP; Tebbutt, NC

Risk predictors of lower-limb amputation in patients with type 2 diabetes mellitus in the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Rajamani, JK Li, L Best, JD Voysey, M Ting, R D’Emden, MC Laakso, M Baker, JR Keech, AC

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial

Rajamani, K Colman, P Li, L Best, J Voysey, M D’Emden, M Laakso, M Baker, J Keech, A FIELD Study Investigators,

Risk predictors of lower-limb amputation in patients with type 2 diabetes mellitus in the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Rajamani, K Li, L Best, JD Voysey, M Ting, RD D’Emden, MC Laakso, M Baker, JR Keech, AC

Benefits and harms of radiotherapy for rectal cancer: meta-analysis of survival and toxicity

Rao, A Hui, A Barton, M Sjoquist, K

Second and third line chemotherapy in advanced gastric or gastro-oesophageal cancer: a single institution retrospective case series and review of the literature

Rao, A Sjoquist, K Goldstein, D

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-up

Regan, MM Neven, P Giobbie-Hurder, A Goldhirsch, A Ejlertsen, B Mauriac, L Forbes, JF Smith, I Lang, I Wardley, A Rabaglio, M Price, KN Gelber, RD Coates, AS Thurlimann, B
LANCET ONCOLOGY, 2011     DOI:10.1016/s1470-2045(11)70270-4

Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer

Regan, MM Price, KN Giobbie-Hurder, A Thurlimann, B Gelber, RD
BREAST CANCER RESEARCH, 2011     DOI:10.1186/bcr2837

Ageing and workforce participation

Schofield, D Callander, E

Labor force participation and the influence of having back problems on income poverty in Australia

Schofield, DJ Callander, EJ Shrestha, RN Percival, R Kelly, SJ Passey, ME

How depression and other mental health problems can affect future living standards of those out of the labour force

Schofield, DJ Kelly, SJ Shrestha, RN Callander, EJ Percival, R Passey, ME
AGING AND MENTAL HEALTH, 2011     DOI:10.1080/13607863.2011.556599

A crisis in the making? Education, ageing populations and the future of the medical research workforce

Schofield, DJ Meachem, S West, C Kavallaris, M Callander, EJ
MEDICAL EDUCATION, 2011     DOI:10.1111/j.1365-2923.2010.03785.x

Retiring early with cardiovascular disease—impact on individual's financial assets [letter]

Schofield, D Passey, M Percival, R Shrestha, R Callander, E Kelly, S
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011     DOI:DOI: 10.1016/j.ijcard.2010.09.092